NCNA
NuCana plc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
nucana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines. while these conventional agents remain part of the standard of care for the treatment of many solid tumours, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. utilising our proprietary protide technology, we are developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells.
Market Cap: 16.9 Million
Primary Exchange: NASDAQ
Website: http://www.nucana.com/
Shares Outstanding: 52.3 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.8970020530858126
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1682 trading days
From: 2018-06-06 To: 2024-03-07
Lowest Point:
NuCana: Improving Standard Chemotherapy Drugs Look Interesting
via: SeekingAlpha at 2019-06-12 09:17:17:000
NuCana plc ( NCNA ) has a platform which enables it to take common and ordinarily effective nucleoside chemotherapy drugs like gemcitabine and overcome cellular resistance to them. This vastly increases the efficacy quotient of these drugs. The company's lead drug candidate is Acelarin, which… read more...
NuCana: Improving Standard Chemotherapy Drugs Look Interesting
via: SeekingAlpha at 2019-06-12 09:17:17:000
NuCana plc ( NCNA ) has a platform which enables it to take common and ordinarily effective nucleoside chemotherapy drugs like gemcitabine and overcome cellular resistance to them. This vastly increases the efficacy quotient of these drugs. The company's lead drug candidate is Acelarin, which… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|